Reflecting back on what he learned as a caregiver for his son, Tom Stockwell discusses how he provides assistance to others as a patient navigator for the Fibrolamellar Cancer Foundation. Stockwell further explains why advocacy and research are so important in rare diseases.
Tom Stockwell and John Hopper remark on the importance of taking a proactive role when making treatment decisions with healthcare professionals and emphasize the value in establishing a survivorship care plan.
Now that we're in an era of personalized medicine, patients should not look at statistics and immediately think that they will determine their fate, says Tom Stockwell, patient navigator at the Fibrolamellar Cancer Foundation.
In recent years, the number of available gynecologic cancer clinical trials has gone down. The Foundation for Women's Cancer educates women about the trials that are available, and encourages them speak up publicly about the need for more.
CURE Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, has expanded its Strategic Alliance Partnership (SAP) Program by uniting with the Lung Cancer Foundation of America (LCFA).